Product Information

INCASSIA 0.35 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0906 per EA under NDC 65862092585. Its NADAC has been published 386 times since Apr 3, 2019.

FDA first approved this application on Sep 23, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

INCASSIA 0.35 MG TABLET

NORETHINDRONE
$0.0906per EA

Strength

.35 mg/1

NDC

65862092585

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

NORETHINDRONE

Approval Type

Generic (ANDA)

FDA Application

ANDA207304

FDA Approved

9/23/2016

TE Code

AB1

On Market Since

9/23/2016

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for INCASSIA 0.35 MG TABLET has been published 386 times since Apr 3, 2019, and over the history we have for it it has declined 37.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0906 per EA
All-time high$0.2295 (Apr 14, 2021)
All-time low$0.0691 (Nov 20, 2024)
52-week high$0.0945
52-week low$0.0849
Median price$0.1456
Average price$0.1498
Largest weekly change+43.4% (Aug 21, 2024)
Weeks tracked386
Tracking sinceApr 3, 2019

Price History

1W

-2.7%

1M

-2.7%

3M

-3.9%

6M

-2.8%

1Y

+2.2%

3Y

-31.9%

5Y

-49.5%

All

-37.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of INCASSIA 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INCASSIA 0.35 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0906 per EA (NDC 65862092585), effective Aug 19, 2026.

How has the price of INCASSIA 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for INCASSIA 0.35 MG TABLET has declined 37.6%. It has been tracked across 386 weekly CMS publications since Apr 3, 2019.

What are the highest and lowest recorded NADAC prices for INCASSIA 0.35 MG TABLET?

Since Apr 3, 2019, the NADAC for INCASSIA 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.2295 (Apr 14, 2021), with a median of $0.1456 per EA.

Are there cheaper alternatives to INCASSIA 0.35 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INCASSIA 0.35 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures INCASSIA 0.35 MG TABLET?

INCASSIA 0.35 MG TABLET (NDC 65862092585) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.